Consult with your healthcare professional before taking any medication.Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Guidelines for Safe Handling of Hazardous Drugs ONS … Drugs to be evaluated include new Food and Drug Administration (FDA) approvals and existing drugs with new FDA warnings, usually black box warnings.GERPAC provides for its members a discussion forum specifically devoted to technology in hospital pharmacy Overview. In addition to the drugs identified by the FDA database searches, the NIOSH Director received a request to evaluate two drugs, dihydroergotamine and isotretinoin, for placement on the List by an interested party. MacroBID. OSHA has identified worker exposure to hazardous drugs as a problem of increasing health concern. Drugs are classified as hazardous when they possess any one of the following six charac-teristics (ASHP, 1990, 2006; National Institute for Occupational Safety and Health [NIOSH], 2004). Select one or more newsletters to continue. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. In the US, MacroBID (nitrofurantoin systemic) is a member of the drug class urinary anti-infectives and is used to treat Bladder Infection, Prevention of Bladder infection and Urinary Tract Infection. We comply with the HONcode standard for trustworthy health information - Tell each of your health care providers about all medicines you use now and any medicine you start or stop using. The NIOSH Hazardous Drug Committee has reviewed all new FDA drug approvals and new drug warnings for the period January 2014 through December 2015. Hazardous Drugs by NIOSH Thomas H. Connor, PhD Research Biologist National Institute for Occupational Safety and Health NIOSH Goals Protect workers from exposure to hazardous drugs Provide best possible guidance Generate hazardous drug list Avoid unnecessary drugs on list Include all hazardous drugs Update on a timely basis U.S. This is why safe handling of hazardous drugs is crucial. The NIOSH criteria include : carcinogenicity, teratogenicity, reproductive toxicity, genotoxicity, organ toxicity at low doses, and drugs that mimic existing drugs in structure or toxicity. NIOSH reviews all new listings and makes recommendations about which drugs are potentially hazardous. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. Available for Android and iOS devices. • Genotoxicity, or the ability to cause a change or mutation in genetic material; a mutagen. See also: Macrobid drug interactions (in more detail) Further information. Important Notice: The Drugs.com international database is in BETA release. Drugs to be evaluated include new Food and Drug Administration (FDA) approvals and existing drugs with new FDA warnings, usually black box warnings. This means it is still under development and may contain inaccuracies. While the majority of the hazardous drugs are cytotoxic antineoplastic drugs, drugs from other classes are included.NIOSH evaluates each drug on an individual basis and does not group drugs into classes. What other drugs will affect Macrobid? NIOSH has developed an extensive review process in order to continuously update its list of hazardous drugs. These drugs can be classified as antineoplastics, cytotoxic agents, biologic agents, antiviral agents and immunosuppressive agents. NIOSH has developed an extensive review process in order to continuously update its list of hazardous drugs. Preparation, administration, manufacturing, and disposal of hazardous medications may expose hundreds of thousands of workers, principally in healthcare facilities and the pharmaceutical industry, to potentially significant workplace levels of these chemicals.
The committee reviewed 73 new drug approvals and 198 drugs with new warnings.